R. Ostlund

Annual review of nutrition · 2003

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Whom R. Ostlund trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Law

Who trusts R. Ostlund overall

  1. J. Awika
  2. C. Curran
  3. Nirmala Chongtham

Papers from R. Ostlund's perspective

Ordered by how strongly the researchers R. Ostlund trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (Journal of the American Pharmacists Association)
  2. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (The Lancet)
  3. The safety of statins in clinical practice. (The Lancet)
  4. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. (The Lancet)
  5. Bias and causal associations in observational research.
  6. Use of statins and the risk of death in patients with prostate cancer. (Journal of Clinical Oncology)
  7. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. (Journal of the American Medical Association (JAMA))
  8. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. (The Lancet)
  9. Evaluating non-randomised intervention studies. (Health Technology Assessment)
  10. Statins and the risk of colorectal cancer. (New England Journal of Medicine)

Their papers